I. Kiladze, Lika Chkhaidze, A. Iovashvili, E. Natelauri, B. Sokurashvili, E. Mariamidze, N. Kacheishvili, B. Jeremic
{"title":"老年癌症食管癌最终放化疗的安全性和疗效","authors":"I. Kiladze, Lika Chkhaidze, A. Iovashvili, E. Natelauri, B. Sokurashvili, E. Mariamidze, N. Kacheishvili, B. Jeremic","doi":"10.1002/pro6.1190","DOIUrl":null,"url":null,"abstract":"Objective: The efficacy and safety of definitive chemoradiotherapy (dCRT) for elderly patients with unresectable esophageal cancer (EC) are not yet fully understood. We conducted this study to evaluate the outcome and toxicity in elder patients (65 years and over) of unresectable EC treated with dCRT.","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Definitive chemoradiotherapy in elderly patients with esophageal cancer: Safety and outcome\",\"authors\":\"I. Kiladze, Lika Chkhaidze, A. Iovashvili, E. Natelauri, B. Sokurashvili, E. Mariamidze, N. Kacheishvili, B. Jeremic\",\"doi\":\"10.1002/pro6.1190\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: The efficacy and safety of definitive chemoradiotherapy (dCRT) for elderly patients with unresectable esophageal cancer (EC) are not yet fully understood. We conducted this study to evaluate the outcome and toxicity in elder patients (65 years and over) of unresectable EC treated with dCRT.\",\"PeriodicalId\":32406,\"journal\":{\"name\":\"Precision Radiation Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Precision Radiation Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/pro6.1190\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Precision Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pro6.1190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Definitive chemoradiotherapy in elderly patients with esophageal cancer: Safety and outcome
Objective: The efficacy and safety of definitive chemoradiotherapy (dCRT) for elderly patients with unresectable esophageal cancer (EC) are not yet fully understood. We conducted this study to evaluate the outcome and toxicity in elder patients (65 years and over) of unresectable EC treated with dCRT.